CINECA IRIS Institutional Research Information System

CAPPAGLI, VIRGINIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.205
EU - Europa 1.763
AS - Asia 1.621
SA - Sud America 294
AF - Africa 129
OC - Oceania 7
Totale 7.019
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.124
IT - Italia 533
SG - Singapore 531
CN - Cina 469
DE - Germania 382
HK - Hong Kong 294
SE - Svezia 257
BR - Brasile 245
GB - Regno Unito 141
BG - Bulgaria 103
VN - Vietnam 101
AT - Austria 90
CI - Costa d'Avorio 64
IN - India 55
CA - Canada 53
RU - Federazione Russa 53
FR - Francia 46
FI - Finlandia 41
TR - Turchia 38
JP - Giappone 30
SN - Senegal 27
BD - Bangladesh 20
MA - Marocco 20
NL - Olanda 20
PL - Polonia 20
AR - Argentina 19
MX - Messico 15
ZA - Sudafrica 13
CZ - Repubblica Ceca 11
IQ - Iraq 11
KR - Corea 11
EC - Ecuador 9
ES - Italia 9
GR - Grecia 9
CO - Colombia 7
ID - Indonesia 7
PH - Filippine 7
PK - Pakistan 7
UZ - Uzbekistan 7
EE - Estonia 6
RO - Romania 6
UA - Ucraina 6
AU - Australia 5
IL - Israele 5
LT - Lituania 5
SA - Arabia Saudita 5
TW - Taiwan 5
CH - Svizzera 4
DK - Danimarca 4
DO - Repubblica Dominicana 4
PY - Paraguay 4
VE - Venezuela 4
AZ - Azerbaigian 3
BE - Belgio 3
CL - Cile 3
IE - Irlanda 3
IR - Iran 3
JO - Giordania 3
PT - Portogallo 3
TT - Trinidad e Tobago 3
AL - Albania 2
GT - Guatemala 2
HN - Honduras 2
HU - Ungheria 2
KE - Kenya 2
LB - Libano 2
MY - Malesia 2
PA - Panama 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
EG - Egitto 1
KI - Kiribati 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LV - Lettonia 1
MM - Myanmar 1
NZ - Nuova Zelanda 1
PE - Perù 1
QA - Qatar 1
UY - Uruguay 1
Totale 7.019
Salva come PNG Salva come JPEG
Città #
Ashburn 400
Dallas 374
Hong Kong 291
Singapore 288
Chandler 245
Fairfield 211
Santa Clara 205
Milan 174
Houston 162
Woodbridge 156
Shanghai 119
New York 104
Seattle 102
Sofia 102
Beijing 95
Wilmington 85
Vienna 83
Cambridge 73
Munich 71
Los Angeles 69
Abidjan 64
Ann Arbor 58
Princeton 54
Boardman 51
Florence 49
London 49
Pisa 49
Rome 44
Frankfurt am Main 42
Lawrence 40
Serra 36
Redmond 32
Medford 29
São Paulo 29
Dakar 27
Ho Chi Minh City 25
Ottawa 24
Bremen 21
Redondo Beach 19
Buffalo 18
Dong Ket 18
Boulder 17
Hefei 17
Tokyo 17
Denver 16
Redwood City 16
Casablanca 15
Des Moines 15
Istanbul 15
San Diego 15
Turku 15
Dearborn 14
Montreal 14
Warsaw 14
Boston 13
Helsinki 12
Washington 12
Atlanta 11
Belo Horizonte 11
Nuremberg 11
Phoenix 11
Bengaluru 10
Chiesina Uzzanese 10
Fuzhou 10
Lancaster 10
Guangzhou 9
Hanoi 9
Johannesburg 9
Chicago 8
Dhaka 8
Düsseldorf 8
Ogden 8
Paris 8
Poplar 8
Rio de Janeiro 8
Scandicci 8
Seoul 8
Amsterdam 7
Brno 7
Brooklyn 7
Hangzhou 7
Izmir 7
Lucca 7
Nanjing 7
Orem 7
San Jose 7
Toronto 7
Ankara 6
Cascina 6
Chengdu 6
Fortaleza 6
Jiaxing 6
Lauterbourg 6
Stockholm 6
Tashkent 6
Vancouver 6
Baghdad 5
Council Bluffs 5
Mumbai 5
Norwalk 5
Totale 4.751
Salva come PNG Salva come JPEG
Nome #
Treatment of advanced thyroid cancer with targeted therapies: Ten years of experience 225
Medullary thyroid cancer treated with vandetanib: predictors of longer and durable response 215
In silico and in vitro analysis of rare germline allelic variants of RET oncogene associated with medullary thyroid cancer 214
Targeted Therapy in Thyroid Cancer: State of the Art 211
Active surveillance in papillary thyroid microcarcinomas is feasible and safe: experience at one single Italian center 207
Protein kinase inhibitors for the treatment of advanced and progressive radiorefractory thyroid tumors: From the clinical trials to the real life 201
Hypertension, nausea, anorexia and weight loss were significantly associated with better progression-free survival in patients with radioiodine-Refractory Differentiated Thyroid Carcinoma treated with Lenvatinib 200
Next generation sequencing revealed RET or RAS mutation in medullary thyroid cancer that were negative at sanger sequencing 192
Lenvatinib therapy in progressive, radioiodine-refractory, differentiated thyroid carcinoma: analysis of 74 cases followed in a single centre 185
Twenty-Five Years Experience on RET Genetic Screening on Hereditary MTC: An Update on The Prevalence of Germline RET Mutations 183
GENETIC SCREENING OF RET CAN IDENTIFY NEW MUTATIONS EVEN AFTER 20 YEARS 179
Il carcinoma tiroideo: nuove prospettive terapeutiche. 172
Clinical, pathological and genetic features of anaplastic and poorly differentiated thyroid cancer: A single institute experience 169
Clinical utility of genetic diagnosis for sporadic and hereditary medullary thyroid carcinoma 163
Fifty years after the first description, the MEN 2B syndrome diagnosisis still late: description of two recent cases 162
Central Neck Dissection Cannot Be Avoided In Medullary Thyroid Cancer (MTC) On The Basis Of Presurgical Serum Calcitonin (CT) 161
GENETIC LANDSCAPE OF SOMATIC MUTATIONS IN A LARGE COHORT OF SPORADIC MEDULLARY THYROID CARCINOMAS STUDIED BY NEXT GENERATION TARGETED SEQUENCING 153
Lenvatinib treatment in the real clinical practice of progressive, radioiodine-refractory differentiated thyroid carcinoma: analysis of a big series followed in a single center 152
AFTER 20 YEARS, RET GENETIC SCREENING STILL INDENTIFIES NEW GERMILINE AND SOMATIC MUTATIONS 151
No difference in the outcome of metastatic thyroid cancer patients when using recombinant or endogenous TSH 145
MON-490 Calcitonin-Based Thyroidectomy Is a Safe Approach in Patients with Germline RET Mutation and Permits to Delay Surgery in Children 145
New insights in the molecular signature of advanced medullary thyroid cancer: Evidence of a bad outcome of cases with double RET mutations 143
OR21-01 Pre-Operative Calcitonin Value as a Predictive Factor of Cancer Related Death in Sporadic Medullary Thyroid Carcinoma 141
Clinical evolution of sporadic medullary thyroid carcinoma with biochemical incomplete response after initial treatment 140
Thyroid cancers: From surgery to current and future systemic therapies through their molecular identities 139
Impact of Advanced Age on the Clinical Presentation and Outcome of Sporadic Medullary Thyroid Carcinoma 132
Calcitonin receptor expression in medullary thyroid carcinoma 131
Systemic treatment of advanced, metastatic, medullary thyroid carcinoma 130
Cabozantinib: An orphan drug for thyroid cancer 127
null 114
After 20 Years, RET genetic screening still identifies new germline and somatic mutations 114
Prevalence and Risk Factors of Developing Fistula or Organ Perforation in Patients Treated with Lenvatinib for Radioiodine-Refractory Thyroid Cancer 114
Proteinuria is a late-onset adverse event in patients treated with cabozantinib 112
RET Copy Number Alteration in Medullary Thyroid Cancer Is a Rare Event Correlated with RET Somatic Mutations and High Allelic Frequency 112
Body Mass Index and Sporadic Medullary Thyroid Cancer: Insights from a Large Series 111
Ret mutated C-cells proliferate more rapidly than non-mutated neoplastic cells 111
Thyroid cancer and COVID-19: experience at one single thyroid disease referral center 110
Long-Term Outcome of Patients with Low-Risk Differentiated Thyroid Cancer Treated with Total Thyroidectomy Alone 109
The Integrity of Tumor Capsule Identifies a Subgroup of Indolent Cases Not Only Among the Follicular (FVPTC) But Also in Classic Variant of Papillary Thyroid Cancer (CVPTC) 106
Active surveillance in differentiated thyroid cancer: a strategy applicable to all treatment categories response 103
Non thyroidal second primary malignancies in differentiated thyroid cancer patients: is the incidence increased comparing to the general population and could it be a radioiodine therapy consequence? 102
Chylous effusions in advanced medullary thyroid cancer patients treated with selpercatinib 100
MON-537 Primary Adrenal Insufficiency During Tyrosine Kinase Inhibitors Treatment in Advanced Thyroid Cancer Patients 98
Clinical Management of a Patient with a Locally Recurrent Medullary Thyroid Cancer and Asymptomatic Slowly Progressing Distant Metastasis. 94
The timing of total thyroidectomy in RET gene mutation carriers could be personalized and safely planned on the basis of serum calcitonin: 18 Years experience at one single center 90
The Usefulness of the International Grading System in the Management of Sporadic Medullary Thyroid Carcinoma 89
Hypothesizing a role of ret hyperactivation on weight control in patients with type 2A multiple endocrine neoplasia (MEN2A) 89
Pre-surgical Value Of Basal Calcitonin Is Not Predictive Of Central Neck Compartment Metastases. 82
Hand-foot syndrome in sorafenib and lenvatinib treatment for advanced thyroid cancer 73
Predictive factors for central neck compartment lymphnodes metastases' in sporadic medullary thyroid cancer patients 72
MULTIFOCALITY AND BILATERALITY IN MEDULLARY THYROID CANCER: BASIS FOR A PROOF-OF-CONCEPT SAFETY OF LOBECTOMY 68
null 58
Fifty Years after the First Description, MEN 2B Syndrome Diagnosis Is Still Late: Descriptions of Two Recent Cases 41
Genetic origin of multifocal sporadic medullary thyroid cancer and C-cell hyperplasia 11
Totale 7.151
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.027
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.027
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021246 0 0 0 0 0 44 24 28 33 25 26 66
2021/2022505 21 15 7 25 100 66 16 20 31 27 43 134
2022/2023956 110 147 76 79 81 106 17 66 180 10 76 8
2023/2024621 59 70 94 55 86 109 22 10 3 5 33 75
2024/20251.702 16 67 22 101 182 150 168 89 162 226 186 333
2025/20261.672 200 398 307 280 288 199 0 0 0 0 0 0
Totale 7.151